A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration
Public ClinicalTrials.gov record NCT04643886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Multiple Dose Study in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration to Evaluate the Safety, Tolerability, Pharmacodynamics, and Immunogenicity of Repeat Intravitreal Injections of GEM103
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to investigate the safety, PK/PD, biomarker and early clinical effects of repeat GEM103 IVT injections.
Study identification
- NCT ID
- NCT04643886
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2020 (Actual)
- Primary completion
- Feb 18, 2022 (Actual)
- Completion
- Mar 21, 2022 (Actual)
- Last update posted
- Sep 23, 2022
2020 – 2022
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gemini Clinical Trial Site | Phoenix | Arizona | 85020 | — |
| Gemini Clinical Trial Site | Bakersfield | California | 93309 | — |
| Gemini Clinical Trial Site | Beverly Hills | California | 90211 | — |
| Gemini Clinical Trial Site | Oxnard | California | 93036 | — |
| Gemini Clinical Trial Site | Poway | California | 92064 | — |
| Gemini Clinical Trial Site | Santa Barbara | California | 93103 | — |
| Gemini Clinical Trial Site | Santa Maria | California | 93454 | — |
| Gemini Clinical Trial Site | Golden | Colorado | 80401 | — |
| Gemini Clinical Trial Site | New London | Connecticut | 06320 | — |
| Gemini Clinical Trial Site | Palm Beach Gardens | Florida | 33410 | — |
| Gemini Clinical Trial Site | St. Petersburg | Florida | 33711 | — |
| Gemini Clinical Trial Site | Tallahassee | Florida | 32308 | — |
| Gemini Clinical Trial Site | Winter Haven | Florida | 33880 | — |
| Gemini Clinical Trial Site | Augusta | Georgia | 30909 | — |
| Gemini Clinical Trial Site | Marietta | Georgia | 30060 | — |
| Gemini Clinical Trial Site | Oak Park | Illinois | 60304 | — |
| Gemini Clinical Trial Site | Indianapolis | Indiana | 46290 | — |
| Gemini Clinical Trial Site | Chesterfield | Missouri | 63017 | — |
| Gemini Clinical Trial Site | St Louis | Missouri | 63144 | — |
| Gemini Clinical Trial Site | Reno | Nevada | 89502 | — |
| Gemini Clinical Trial Site | Bloomfield | New Jersey | 07003 | — |
| Gemini Clinical Trial Site | Asheville | North Carolina | 28803 | — |
| Gemini Clinical Trial Site | Charlotte | North Carolina | 28210 | — |
| Gemini Clinical Trial Site | Eugene | Oregon | 97401 | — |
| Gemini Clinical Trial Site | Rapid City | South Dakota | 57701 | — |
| Gemini Clinical Trial Site | Abilene | Texas | 79606 | — |
| Gemini Clinical Trial Site | Dallas | Texas | 75231 | — |
| Gemini Clinical Trial Site | The Woodlands | Texas | 77384 | — |
| Gemini Clinical Trial Site | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04643886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2022 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04643886 live on ClinicalTrials.gov.